Your session is about to expire
← Back to Search
Facilitated Genetic Testing for BRCA Mutation
Study Summary
This trial will compare the efficacy of a multicomponent facilitated intervention vs. standard care in terms of the overall proportion of first degree relatives who complete genetic testing for inherited gynecologic/breast cancer syndromes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a close family member at risk due to our shared genetics.My cancer has a BRCA1 or BRCA2 mutation.I am 18 years old or older.I can speak and read either English or Spanish.I have a new or confirmed BRCA mutation within the last year.
- Group 1: Exploratory Arm
- Group 2: Intervention - Facilitated cascade testing
- Group 3: Standard of care - Proband-mediated cascade testing
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for volunteers in this clinical experiment?
"Affirmative. Per information hosted on clinicaltrials.gov, the trial is actively enrolling participants. This research was put up on July 21st 2021 and its latest update happened August 12th 2022; 600 subjects are needed from 3 distinct places of study."
How many participants are currently involved in this research endeavor?
"Affirmative. Clinicaltrials.gov lists this medical trial as being actively recruiting, with the initial posting on July 21st 2021 and last edited on August 12th 2022. 600 patients need to be recruited from 3 different sites for this study."
Share this study with friends
Copy Link
Messenger